Cetrak 10 mg 20 tablets
Pharco Pharmaceuticals Inc.
Pharco Pharmaceuticals Inc.
Composition
Each tablet contains
Cetirizine dihydrochloride – 10 mg.
Inactive ingredients: lactose monohydrate, corn starch, Povidone K, croscarmellose sodium, magnesium stearate, talcum powder, hydroxypropyl methylcellulose, titanium dioxide, propylene glycol.
Properties
Cetirizine dihydrochloride is a histamine antagonist, a metabolite of hydroxyzine, and blocks H1-histamine receptors. Prevents the development and facilitates the course of allergic reactions, has antipruritic and antiexudative action. Reduces capillary permeability, prevents the development of tissue edema, relieves smooth muscle spasm. In therapeutic doses, it practically does not cause a sedative effect.
Indications
For the relief of nasal and ocular symptoms of seasonal and perennial allergic rhinitis. For the treatment of symptoms of chronic idiopathic urticaria.
Mode of application
Adults and adolescents over 12 years of age: 10 mg (1 tablet) once a day.
Contraindications
-Children under 12 years old;
-H ypersensitivity to the active substance, any of the other components in the composition, to hydroxyzine or any piperazine derivatives. Patients with severe renal impairment. Patients with rare hereditary problems of galactose intolerance, glucose-galactose malabsorption. Pregnancy and lactation.
Warnings and precautions
-Patients with hepatic impairment: dose adjustment is not required in patients.
-Patients with renal impairment: dose adjustment is recommended.
Side effects
•insignificant effect on the central nervous system – drowsiness, dizziness, headache, fatigue; difficulty urinating, dry mouth, abdominal pain, nausea, diarrhea, increased appetite.
Storage
Store at a temperature not exceeding 30°C in a dry place out of the reach of children.
Package
Carton box contains 1 or 2 blisters of 10 p / o tablets and inner leaflet.